Kidney Transplantation in Patients With Sickle Cell Disease
Stopped early
Conditions studied: Sickle Cell Disease
In brief
The purpose of this research is to better characterize the components and mechanisms of the immune systems of persons with sickle cell disease who have had a kidney transplant and are immunosuppressed. If we can improve our scientific understanding of the fundamental mechanisms involved in patient outcomes, we can potentially maximize the benefits that we seek from transplantation in sickle cell patients with end stage renal disease.
Key facts
- Study ID
- NCT00663507
- Run by
- Emory University
- People needed
- 2
- Starts
- 2008-03-01
- Expected to finish
- 2010-12-01
- Last updated by the study team
- 2013-02-27
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Male or female patients between 18 and 65 years of age
- Patients capable of understanding the purposes and risks of the study, who can give written informed consent and who are willing to participate in and comply with the study.
- Women of childbearing potential must have a negative serum pregnancy test within 7 days prior to enrollment and must not be breast-feeding.
- Patients must be diagnosed with Sickle Cell Disease (SS phenotype)
You may not qualify if…
- Patients with any prior organ transplant or multi-organ transplant recipients.
- Patients with evidence of an active systemic infection requiring the continued use of antibiotics, evidence of an HIV infection, or the presence of a chronic active hepatitis B or C.
- Patients with history of malignancy in the last 5 years (except successfully treated localized non-melanotic skin cancer)
- Patients with active illegal drug use
Where it is running
- Mason Outpatient Tranplant Clinic Emory University — Atlanta, Georgia, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.